COPD 2015

Key Topics

• Formulation developments and the manufacturing of dry powder inhalation products
• The advantages and disadvantages of combinational therapeutics
• Challenges in clinical trial designs and in drug development
• COPD and comorbidities
• ACOS Definition and characteristics of a grey-zone syndrome, excluded from current asthma and COPD trials
• "first in class" inhaled drugs for the treatment of COPD and cystic fibrosis
• Role of lymphoid follicles in COPD Novel delivery and formulation methods
• Recent advances made in COPD biomarkers

Who should Attend

Attendees involved or interested in:

• Respiratory Pharmacology
• Respiratory Physiology & Medicine
• Inflammatory Disease
• Medical Affairs
• Pulmonary Disease
• Respiratory, Inflammation and Autoimmunity
• Immunology
• Respiratory Therapeutics
• In-Vitro Biology
• Medical & Inhalation Devices
• Inflammation Discovery
• Biomarker
• Clinical Pharmacology
• Preclinical R&D
• Clinical Science
• Clinical Trials
• Global Data Informatics
• Discovery
• Brand Manager
• Business Development
• Respiratory Licensing & Regulation
• Commercial